PopVax
PrivateLast Round
Grant
Sep 1, 2025
Total Funding Raised
$35.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PopVax operates in Healthcare & Life Sciences and is based in Hyderabad. Its latest recorded funding round was a Grant round in September 2025.
PopVax is a biotechnology company that develops mRNA vaccines and therapeutics using machine learning-driven computational protein design.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PopVax Comparables
Compare PopVax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Providence Therapeutics | 85% | |
| Abogen Biosciences | 78% | |
| Innovac Therapeutics | 76% |
For institutional investors. Book with your work email.
PopVax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2025 | ||||
| Grant | Jan 13, 2025 | ||||
| Grant | Oct 29, 2024 | ||||
| Grant | Aug 1, 2023 |
For institutional investors. Book with your work email.
PopVax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Good Ventures | Seed |
| Balvi Fund | Grant |
| Renaissance Philanthropy | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 114% MoM, reaching 16.1K.
- Apr 24, 2026
Grew 16% QoQ, from 70 to 81 employees.
For institutional investors. Book with your work email.
PopVax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PopVax's valuation, stock price, and market status.
Is PopVax a public or private company?
PopVax is a private company.
What is the current stock price of PopVax?
PopVax is a private company, so its shares have no public market price. Caplight tracks PopVax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PopVax worth (valuation)?
Valuation information for PopVax is not publicly available.
Can I buy PopVax stock?
PopVax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PopVax's last funding round?
PopVax's most recent funding round was Grant on September 1, 2025.
Who are the main investors in PopVax?
Key investors in PopVax include Good Ventures.
Will PopVax IPO soon?
No public IPO plans have been announced for PopVax.
How can I track PopVax secondary market activity?
Caplight tracks bids, offers, and trades in PopVax's shares on secondary markets.